Cargando…
COVID-19 vaccination in patients with immune thrombocytopenia
Immune thrombocytopenia (ITP) is an acquired autoimmune disorder that is characterized by low platelet count and increased bleeding risk. COVID-19 vaccination has been described as a risk factor for de novo ITP, but the effects of COVID-19 vaccination in patients with ITP are unknown. We aimed to in...
Autores principales: | Visser, Chantal, Swinkels, Maurice, van Werkhoven, Erik D., Croles, F. Nanne, Noordzij-Nooteboom, Heike S., Eefting, Matthijs, Last-Koopmans, Suzanne M., Idink, Cecile, Westerweel, Peter E., Santbergen, Bart, Jobse, Pieter A., Baboe, Fazil, te Boekhorst, Peter A. W., Leebeek, Frank W. G., Levin, Mark-David, Kruip, Marieke J. H. A., Jansen, A. J. Gerard |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Hematology
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8709724/ https://www.ncbi.nlm.nih.gov/pubmed/34941989 http://dx.doi.org/10.1182/bloodadvances.2021006379 |
Ejemplares similares
-
The Effect of COVID-19 Vaccine in Patients with Immune Thrombocytopenia
por: Visser, Chantal, et al.
Publicado: (2021) -
Serum from half of patients with immune thrombocytopenia trigger macrophage phagocytosis of platelets
por: Norris, Peter A. A., et al.
Publicado: (2023) -
Platelet gene expression and function in patients with COVID-19
por: Manne, Bhanu Kanth, et al.
Publicado: (2020) -
Platelet functional abnormalities in pediatric patients with kaposiform hemangioendothelioma/Kasabach-Merritt phenomenon
por: Martyanov, Alexey A., et al.
Publicado: (2023) -
The tyrosine phosphatase CD148 is an essential positive regulator of platelet activation and thrombosis
por: Senis, Yotis A., et al.
Publicado: (2009)